Does the Different Locations of Colon Cancer Affect the Oncologic Outcome? A Propensity-Score Matched Analysis

다국어 초록 (Multilingual Abstract)

Purpose: We evaluate the prognostic value of primary tumor location for oncologic outcomes in patients with colon cancer (CC).
Methods: CC patients treated with curative surgery between 2009 and 2012 were classified into 2 groups: right-sided colon cancer (RCC) and left-sided colon cancer (LCC). Recurrence-free survival (RFS) and overall survival (OS) were examined based on tumor stage. Propensity scores were created using eight variables (age, sex, T stage, N stage, histologic grade, presence of lymphovascular invasion/perineural invasion, and microsatellite instability status).
Results: Overall, 2,329 patients were identified. The 5-year RFSs for RCC and LCC patients were 89.7% and 88.4% (P = 0.328), respectively, and their 5-year OSs were 90.9% and 93.4% (P = 0.062). Multivariate survival analyses were carried out by using the Cox regression proportional hazard model. In the unadjusted analysis, a marginal increase in overall mortality was seen in RCC patients (hazard ratio [HR], 1.297; 95% confidence interval [CI], 0.987–1.704, P = 0.062); however, after multivariable adjustment, similar OSs were observed in those patients (HR, 1.219; 95% CI, 0.91–1.633; P = 0.183). After propensity-score matching with a total of 1,560 patients, no significant difference was identified (P = 0.183). A slightly worse OS was seen for stage III RCC patients (HR, 1.561; 95% CI, 0.967–2.522; P = 0.068) than for stage III LCC patients. The 5-year OSs for patients with stage III RCC and stage III LCC were 85.5% and 90.5%, respectively (P = 0.133).
Conclusion: Although the results are inconclusive, tumor location tended to be associated with OS in CC patients with lymph node metastasis, but it was not related to oncologic outcome.

참고문헌 (Reference)

1 Yahagi M, "The worse prognosis of right-sided compared with left-sided colon cancers : a systematic review and meta-analysis" 20 : 648-655, 2016

2 Holch JW, "The relevance of primary tumour location in patients with metastatic colorectal cancer : a meta-analysis of first-line clinical trials" 70 : 87-98, 2017

3 Papagiorgis P, "The impact of tumor location on the histopathologic expression of colorectal cancer" 11 : 317-321, 2006

4 Chaiyapan W, "Somatic mutations of K-ras and BRAF in Thai colorectal cancer and their prognostic value" 14 : 329-332, 2013

5 Böckelman C, "Risk of recurrence in patients with colon cancer stage II and III : a systematic review and meta-analysis of recent literature" 54 : 5-16, 2015

6 Sunakawa Y, "Prognostic impact of primary tumor location on clinical outcomes of metastatic colorectal cancer treated with cetuximab plus oxaliplatin-based chemotherapy: a subgroup analysis of the JACCRO CC-05/06 Trials" 16 : e171-e180, 2017

7 Arrington AK, "Prognostic and predictive roles of KRAS mutation in colorectal cancer" 13 : 12153-12168, 2012

8 Sabine Tejpar, "Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer" American Medical Association (AMA) 3 (3): 194-, 2017

9 Fausto Petrelli, "Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer" American Medical Association (AMA) 3 (3): 211-, 2017

10 Hansen IO, "Possible better long-term survival in left versus right-sided colon cancer - a systematic review" 59 : A4444-, 2012

11 Suttie SA, "Outcome of right-and left-sided colonic and rectal cancer following surgical resection" 13 : 884-889, 2011

12 Weiss JM, "Mortality by stage for right-versus left-sided colon cancer : analysis of surveillance, epidemiology, and end results--Medicare data" 29 : 4401-4409, 2011

13 Gill SR, "Metagenomic analysis of the human distal gut microbiome" 312 : 1355-1359, 2006

14 Mostert B, "KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue" 133 : 130-141, 2013

15 Liu F, "Is there a prognostic value of tumor location among Chinese patients with colorectal cancer?" 8 : 38682-38692, 2017

16 Meguid RA, "Is there a difference in survival between right-versus left-sided colon cancers?" 15 : 2388-2394, 2008

17 Ishihara S, "Impact of primary tumor location on postoperative recurrence and subsequent prognosis in nonmetastatic colon cancers : a multicenter retrospective study using a propensity score analysis" 267 : 917-921, 2018

18 Elez E, "First-line treatment of metastatic colorectal cancer : interpreting FIRE-3, PEAK, and CALGB/SWOG 80405" 16 : 52-, 2015

19 Shen H, "Different treatment strategies and molecular features between right-sided and left-sided colon cancers" 21 : 6470-6478, 2015

20 Frattini M, "Different genetic features associated with colon and rectal carcinogenesis" 10 (10): 4015-4021, 2004

21 Nawa T, "Differences between right-and left-sided colon cancer in patient characteristics, cancer morphology and histology" 23 : 418-423, 2008

22 Moritani K, "Difference in the recurrence rate between right-and left-sided colon cancer : a 17-year experience at a single institution" 44 : 1685-1691, 2014

23 Benedix F, "Comparison of 17, 641 patients with right-and left-sided colon cancer : differences in epidemiology, perioperative course, histology, and survival" 53 : 57-64, 2010

24 Compton CC, "Colorectal carcinoma : diagnostic, prognostic, and molecular features" 16 : 376-388, 2003

25 Benson AB 3rd, "American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer" 22 : 3408-3419, 2004